The impact of Toll-like-receptor-9 on intestinal microbiota composition and extra-intestinal sequelae in experimental Toxoplasma gondii induced ileitis

Gut Pathogens

Volumn 6, Issue 1, 2014, Pages

  Bereswill, Stefan ^a   Kühl, Anja A ^a   Alutis, Marie ^a   Fischer, André ^a   Möhle, Luisa ^b   Struck, Daniela ^a   Liesenfeld, Oliver ^a   Göbel, Ulf B ^a   Dunay, Ildikò R ^b   Heimesaat, Markus M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Acute ileitis; Bacterial translocation; Bifidobacteria; Extra intestinal immune responses; FOXP3; Gut brain axis; Intestinal microbiota composition; Intracerebral inflammation; Pro inflammatory cytokines; Regulatory T cells; Systemic inflammatory response; Th1 type immunopathology; TLR 9; Toxoplasma gondii

Indexed keywords

EID: 84902550044     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-6-19     Document Type: Article

References (51)

1. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. Liesenfeld O, Kosek J, Remington JS, Suzuki Y, J Exp Med 1996 184 597 607 10.1084/jem.184.2.597 8760813
2. Immunology of Toxoplasma gondii. Munoz M, Liesenfeld O, Heimesaat MM, Immunol Rev 2011 240 269 285 10.1111/j.1600-065X.2010.00992.x 21349099
3. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Khan IA, Schwartzman JD, Matsuura T, Kasper LH, Proc Natl Acad Sci U S A 1996 94 13955 13960
4. TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Liesenfeld O, Kang H, Park D, Nguyen TA, Parkhe CV, Watanabe H, Abo T, Sher A, Remington JS, Suzuki Y, Parasite Immunol 1999 21 365 376 10.1046/j.1365-3024.1999.00237.x 10417671
5. Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen. Mennechet FJL, Kasper H, Rachinel N, Li W, Vandewalle A, Buzoni-Gatel D, J Immunol 2002 168 2988 2996 10.4049/jimmunol.168.6.2988 11884471
6. Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control. Vossenkamper A, Struck D, Alvarado-Esquivel C, Went T, Takeda K, Akira S, Pfeffer K, Alber G, Lochner M, Forster I, Liesenfeld O, Eur J Immunol 2004 34 3197 3207 10.1002/eji.200424993 15368276
7. Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections. Buzoni-Gatel D, Schulthess J, Menard LC, Kasper LH, Cell Microbiol 2006 8 535 544 10.1111/j.1462-5822.2006.00692.x 16548880
8. Oral infection of C57BL/6 mice with Toxoplasma gondii: a new model of inflammatory bowel disease? Liesenfeld O, J Infect Dis 2002 185 Suppl 1 96 S101 11865446
9. Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, Niebergall J, Jahn HK, Dunay IR, Moter A, Gescher DM, Schumann RR, Göbel UB, Liesenfeld O, J Immunol 2006 177 8785 8795 10.4049/jimmunol.177.12.8785 17142781
10. Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg JM, Blaut M, Liesenfeld O, Schumann RR, Göbel UB, Bereswill S, Gut 2007 56 941 948 10.1136/gut.2006.104497 17255219
11. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5. Erridge C, Duncan SH, Bereswill S, Heimesaat MM, PLoS One 2011 5 9125
12. A Toll-like receptor recognizes bacterial DNA. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S, Nature 2000 408 740 745 10.1038/35047123 11130078
13. Toll-like receptors in innate immunity. Takeda K, Akira S, Int Immunol 2005 17 1 14 15585605
14. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Rutz M, Metzger J, Gellert T, Luppa P, Lipford GB, Wagner H, Bauer S, Eur J Immunol 2004 34 2541 2550 10.1002/eji.200425218 15307186
15. Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, Suzuki N, Ohba Y, Takaoka A, Yeh WC, Taniguchi T, Proc Natl Acad Sci U S A 2004 101 15416 15421 10.1073/pnas.0406933101 15492225
16. CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-kappaB-independent pathways. Kim JM, Kim NI, Oh YK, Kim YJ, Youn J, Ahn MJ, Int Immunol 2005 17 1525 1531 10.1093/intimm/dxh345 16263754
17. TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. Minns LA, Menard LC, Foureau DM, Darche S, Ronet C, Mielcarz DW, Buzoni-Gatel D, Kasper LH, J Immunol 2006 176 7589 7597 10.4049/jimmunol.176.12.7589 16751405
18. Innate immunity to Toxoplasma gondii infection. Yarovinsky F, Nat Rev Immunol 2014 14 109 121 10.1038/nri3598 24457485
19. Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12 heterodimers imparts resistance to Toxoplasma gondii in mice. Andrade WA, Souza Mdo C, Ramos-Martinez E, Nagpal K, Dutra MS, Melo MB, Bartholomeu DC, Ghosh S, Golenbock DT, Gazzinelli RT, Cell Host Microbe 2013 13 42 53 10.1016/j.chom.2012.12.003 23290966
20. Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Benson A, Pifer R, Behrendt CL, Hooper LV, Yarovinsky F, Cell Host Microbe 2009 6 187 196 10.1016/j.chom.2009.06.005 19683684
21. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. Suzuki Y, Sher A, Yap G, Park D, Neyer LE, Liesenfeld O, Fort M, Kang H, Gufwoli E, J Immunol 2000 164 5375 5382 10.4049/jimmunol.164.10.5375 10799901
22. Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. Munoz M, Heimesaat MM, Danker K, Struck D, Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, Loddenkemper C, Krell HW, Libert C, Lund LR, Frey O, Holscher C, Iwakura Y, Ghilardi N, Ouyang W, Kamradt T, Sabat R, Liesenfeld O, J Exp Med 2009 206 3047 3059 10.1084/jem.20090900 19995958
23. Role of the microbiota in immunity and inflammation. Belkaid Y, Hand TW, Cell 2014 157 121 141 10.1016/j.cell.2014.03.011 24679531
24. TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii. Foureau DM, Mielcarz DW, Menard LC, Schulthess J, Werts C, Vasseur V, Ryffel B, Kasper LH, Buzoni-Gatel D, J Immunol 2010 184 7022 7029 10.4049/jimmunol.0901642 20488791
25. The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. Heimesaat MM, Dunay IR, Fuchs D, Trautmann D, Fischer A, Kühl AA, Loddenkemper C, Siegmund B, Batra A, Bereswill S, Liesenfeld O, Eur J Microbiol Immunol (Bp) 2011 1 302 310 10.1556/EuJMI.1.2011.4.6 24516737
26. Quantitative PCR assays for mouse enteric flora reveal strain-dependent differences in composition that are influenced by the microenvironment. Deloris Alexander A, Orcutt RP, Henry JC, Baker JJR, Bissahoyo AC, Threadgill DW, Mamm Genome 2006 17 1093 1104 10.1007/s00335-006-0063-1 17091319
27. Colonization dynamics of altered Schaedler flora is influenced by gender, aging, and Helicobacter hepaticus infection in the intestines of Swiss Webster mice. Ge Z, Feng Y, Taylor NS, Ohtani M, Polz MF, Schauer DB, Fox JG, Appl Environ Microbiol 2006 72 5100 5103 10.1128/AEM.01934-05 16820515
28. Epithelial barrier disruption allows nondisease-causing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse. Sydora BC, Macfarlane SM, Walker JW, Dmytrash AL, Churchill TA, Doyle J, Fedorak RN, Inflamm Bowel Dis 2007 13 947 954 10.1002/ibd.20155 17427241
29. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Bloom SM, Bijanki VN, Nava GM, Sun L, Malvin NP, Donermeyer DL, Dunne WMJR, Allen PM, Stappenbeck TS, Cell Host Microbe 2011 9 390 403 10.1016/j.chom.2011.04.009 21575910
30. Microbial influences in inflammatory bowel diseases. Sartor RB, Gastroenterology 2008 134 577 594 10.1053/j.gastro.2007.11.059 18242222
31. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. Sartor RB, Gastroenterology 2010 139 1816 1819 10.1053/j.gastro.2010.10.036 21029802
32. Bifidobacterium animalis AHC7 protects against pathogen-induced NF-kappaB activation in vivo. O'Mahony D, Murphy S, Boileau T, Park J, O'Brien F, Groeger D, Konieczna P, Ziegler M, Scully, Shanahan PF, Kiely B, O'Mahony L, BMC Immunol 2010 11 63 10.1186/1471-2172-11-63 21176205
33. Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. Dunay IR, Heimesaat MM, Bushrab FN, Muller RH, Stocker H, Arasteh K, Kurowski M, Fitzner R, Borner K, Liesenfeld O, Antimicrob Agents Chemother 2004 48 4848 4854 10.1128/AAC.48.12.4848-4854.2004 15561866
34. Spinal cord pathology in chronic experimental Toxoplasma gondii infection. Mohle L, Parlog A, Pahnke J, Dunay IR, Eur J Microbiol Immunol (Bp) 2014 4 65 75 10.1556/EuJMI.4.2014.1.6 24678407
35. Gr1 (+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Dunay IR, Damatta A, Fux B, Presti R, Greco S, Colonna M, Sibley LD, Immunity 2008 29 306 317 10.1016/j.immuni.2008.05.019 18691912
36. Encephalopathy of infection and systemic inflammation. Young GB, J Clin Neurophysiol 2013 30 454 461 10.1097/WNP.0b013e3182a73d83 24084178
37. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. Mishra BB, Mishra PK, Teale JM, J Neuroimmunol 2006 181 46 56 10.1016/j.jneuroim.2006.07.019 17011049
38. Evaluating the role of Toll-like receptors in diseases of the central nervous system. Carty M, Bowie AG, Biochem Pharmacol 2011 81 825 837 10.1016/j.bcp.2011.01.003 21241665
39. Inflammatory bowel disease: is the intestine a Trojan horse? Basset C, Holton J, Sci Prog 2002 85 33 56 10.3184/003685002783238861 11969118
40. Down-regulation of adhesion molecules and matrix metalloproteinases by ZK 156979 in inflammatory bowel diseases. Martinesi M, Treves C, Bonanomi AG, Milla M, Bagnoli S, Zuegel, Steinmeyer UA, Stio M, Clin Immunol 2010 136 51 60 10.1016/j.clim.2010.03.004 20399147
41. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice. Naito Y, Takagi T, Kuroda M, Katada K, Ichikawa H, Kokura S, Yoshida N, Okanoue NT, Yoshikawa T, Inflamm Res 2004 53 462 468 10.1007/s00011-004-1281-1 15550999
42. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Wang M, Qin X, Mudgett JS, Ferguson TA, Senior RM, Welgus HG, Proc Natl Acad Sci U S A 1999 96 6885 6889 10.1073/pnas.96.12.6885 10359808
43. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Heimesaat MM, Nogai A, Bereswill S, Plickert R, Fischer A, Loddenkemper C, Steinhoff U, Tchaptchet S, Thiel E, Freudenberg MA, Göbel UB, Uharek L, Gut 2010 59 1079 1087 10.1136/gut.2009.197434 20639251
44. Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni? Heimesaat MM, Plickert R, Fischer A, Göbel UB, Bereswill S, Eur J Microbiol Immunol (Bp) 2013 3 36 43 10.1556/EuJMI.3.2013. 1.5 24265916
45. Novel murine infection models provide deep insights into the "Menage a Trois" of Campylobacter jejuni, microbiota and host innate immunity. Bereswill S, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, Dashti JL, Zautner AE, Munoz M, Loddenkemper C, Gross U, Göbel UB, Heimesaat MM, PLoS One 2011 6 20953 10.1371/journal.pone.0020953 21698299
46. Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/- mice via Toll-like-receptor-2 and -4 signaling. Haag LM, Fischer A, Otto B, Plickert R, Kühl AA, Göbel UB, Bereswill S, Heimesaat MM, PLoS One 2012 7 40761 10.1371/journal.pone.0040761 22808254
47. Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Heimesaat MM, Haag LM, Fischer A, Otto B, Kühl AA, Göbel UB, Bereswill S, Eur J Microbiol Immunol (Bp) 2013 3 174 182 10.1556/EuJMI.3.2013.3.4 24265935
48. Small intestinal nematode infection of mice is associated with increased enterobacterial loads alongside the intestinal tract. Rausch S, Held J, Fischer A, Heimesaat MM, Kühl AA, Bereswill S, Hartmann S, PLoS One 2013 8 74026 10.1371/journal.pone.0074026 24040152
49. Comprehensive postmortem analyses of intestinal microbiota changes and bacterial translocation in human flora associated mice. Heimesaat MM, Boelke S, Fischer A, Haag LM, Loddenkemper C, Kühl AA, Göbel UB, Bereswill S, PLoS One 2012 7 40758 10.1371/journal.pone.0040758 22808253
50. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA, J Neuroimmunol 2005 165 63 74 10.1016/j.jneuroim.2005.04.018 16005735
51. Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control. Butcher BA, Fox BA, Rommereim LM, Kim SG, Maure KJ, Yarovinsky F, Herbert DR, Bzik DJ, Denker EY, PLoS Pathog 2011 7 1002236 10.1371/journal.ppat.1002236 21931552